LGND compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

LGNDLigand Pharmaceuticals Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

LGNDLigand Pharmaceuticals Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LGNDLigand Pharmaceuticals Inc

300.62▼−4.91%· post 298.00

Mkt cap$6.0BRevenue$79MQ3 FY26Revenue$268MFY25

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

ClosedNov 5 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 5 '26

LGNDLigand Pharmaceuticals Inc

LLYELI Lilly & Co

300.62▼−4.91%post 298.00

Price

1,371.32▼−3.29%post 1,363.77

$6.0B

Mkt cap

$1.3T

Q3 FY26$79M

Revenue

$24.4BQ3 FY26

FY25$268M

Revenue

$65.2BFY25

LGND300.62▼−4.91%vsLLY1,371.32▼−3.29%ClosedNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

LGND: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LGND 28

MRKMerckcustomer

AMGNAmgencustomer

GILDGileadcustomer

JAZZJazz Pharmaceuticalscustomer

24 more · LGND chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

LGND, solidLLY, dashed